Beijing Trust&Far TechnologyLTD Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Trust&Far TechnologyLTD has a total shareholder equity of CN¥1.6B and total debt of CN¥879.2M, which brings its debt-to-equity ratio to 55.8%. Its total assets and total liabilities are CN¥2.8B and CN¥1.2B respectively. Beijing Trust&Far TechnologyLTD's EBIT is CN¥77.4M making its interest coverage ratio 3.9. It has cash and short-term investments of CN¥330.6M.
Key information
55.8%
Debt to equity ratio
CN¥879.21m
Debt
| Interest coverage ratio | 3.9x |
| Cash | CN¥330.56m |
| Equity | CN¥1.58b |
| Total liabilities | CN¥1.21b |
| Total assets | CN¥2.79b |
Recent financial health updates
Beijing Trust&Far TechnologyLTD (SZSE:300231) Has A Somewhat Strained Balance Sheet
Oct 30
Is Beijing Trust&Far TechnologyLTD (SZSE:300231) A Risky Investment?
Feb 27Recent updates
Revenues Not Telling The Story For Beijing Trust&Far Technology CO.,LTD (SZSE:300231) After Shares Rise 34%
Dec 02Some Investors May Be Willing To Look Past Beijing Trust&Far TechnologyLTD's (SZSE:300231) Soft Earnings
Nov 05Beijing Trust&Far TechnologyLTD (SZSE:300231) Has A Somewhat Strained Balance Sheet
Oct 30Beijing Trust&Far TechnologyLTD (SZSE:300231) Has Announced A Dividend Of CN¥0.20
May 26Why Beijing Trust&Far TechnologyLTD's (SZSE:300231) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 30Beijing Trust&Far Technology CO.,LTD (SZSE:300231) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Mar 04Is Beijing Trust&Far TechnologyLTD (SZSE:300231) A Risky Investment?
Feb 27Financial Position Analysis
Short Term Liabilities: 300231's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥829.6M).
Long Term Liabilities: 300231's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥382.8M).
Debt to Equity History and Analysis
Debt Level: 300231's net debt to equity ratio (34.8%) is considered satisfactory.
Reducing Debt: 300231's debt to equity ratio has reduced from 71.1% to 55.8% over the past 5 years.
Debt Coverage: 300231's debt is not well covered by operating cash flow (14.6%).
Interest Coverage: 300231's interest payments on its debt are well covered by EBIT (3.9x coverage).